Blood schizontocidal activity of selected 1,2,4-trioxanes (Fenozans) against the multidrug-resistant strain of Plasmodium yoelii nigeriensis (MDR) in vivo

Parasitology

Volumn 133, Issue 1, 2006, Pages 1-9

  Tripathi, R ^a   Jefford, C W ^b   Dutta, G P ^c  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c Chattar Manzil Palace ^*  (India)

Author keywords

Antimalarials; Fenozans; Multidrug resistant (MDR); Plasmodium yoelii nigeriensis; Trioxanes

Indexed keywords

1,2,4 TRIOXANE DERIVATIVE; ARACHIS OIL; CYCLOPENTANE DERIVATIVE; DIMETHYL SULFOXIDE; POLYSORBATE; PYRAN DERIVATIVE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; IN VIVO STUDY; MALARIA; MALE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PLASMODIUM YOELII; PRIORITY JOURNAL; SCHIZONT;

ADMINISTRATION, ORAL; ANIMALS; ANTIMALARIALS; BIOLOGICAL ASSAY; DRUG RESISTANCE, MULTIPLE; HUMANS; MALARIA; MICE; PHENYLPROPIONATES; PLANT OILS; PLASMODIUM YOELII; RANDOM ALLOCATION; STRUCTURE-ACTIVITY RELATIONSHIP; TREATMENT OUTCOME;

ARACHIS HYPOGAEA; PLASMODIUM YOELII NIGERIENSIS;

EID: 33745081807     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182006009905     Document Type: Article

References (28)

1. Anon (1982a). China Cooperative Research Group on Qinghaosu and its derivative antimalarials: the chemistry and synthesis of qinghaosu derivatives. Journal of Traditional Chinese Medicine 2, 9-16.
2. Anon (1982b). China Cooperative Research Group on Qinghaosu and its derivatives as antimalarials: antimalarial efficacy and mode of action of qinghaosu and its derivatives in experimental models. Journal of Traditional Chinese Medicine 2, 17-24.
3. Anon (2001). The artemether-quinine metaanalysis study group. A metaanalysis using individual patient data of trials comprising artemether with quinine in the treatment of severe falciparum malaria. Transactions of the Royal Society Tropical Medicine and Hygiene 95, 637-650.
4. Awad, M. I., Alkadru, A. M. Y., Behrens, R. H., Baraka, Q. Z. and Eltayeb, I. B. (2003). Descriptive study on the efficacy and safety of artesunate suppository in combination with other antimalarials in the treatment of severe malaria in Sudan. American Journal of Tropical Medicine and Hygiene 68, 153-158.
5. Dutta, G. P. and Tripathi, R. (1996). Arteether α/β - a fast acting antimalarial. Japanese Journal of Tropical Medicine and Hygiene 24, 65-69.
6. Dutta, G. P. and Tripathi, R. (2003). New antimalarial drug development in India: α/β Arteether. Proceedings of the Indian National Science Academy 69B, 861-870.
7. Jefford, C. W., McGoran, E. C., Boukouvalas, J., Richardson, G., Robinson, B. L. and Peters, W. (1988). Synthesis of new 1,2,4-trioxanes and their antimalarial activity. Helvetica Chimica Acta 71, 1805-1812.
8. Jefford, C. W., Velarde, J. A., Bernardinelli, G., Bray, D. H., Warhurst, D. C. and Milhous, W. K. (1993). Synthesis, structure and antimalarial activity of Tricyclic 1,2,4-trioxanes related to artemisinin. Helvetica Chimica Acta 76, 2775-2778.
9. Jefford, C. W., Shigeo Kohmoto, S., Jaggi, D., Timari, G., Rossier, J. C., Rudaz, M., Barbuzzi, O., Gerard, D., Burger, U., Kamlaprija, P., Mareda, J., Bernardinelli, G., Manzanares, I., Canfield, C. J., Fleck, S. L., Robinson, B. L. and Peters, W. (1995). Synthesis, structure and antimalarial activity of some enantiomerically pure, cis-fused cyclopenteno 1,2,4-trioxanes. Helvetica Chimica Acta 78, 647-662.
10. Jerrold, H. Z. (1974). Biostastical Analysis. Prentice-Hall, Inc, New Jersey, USA.
11. Meshnick, S. R., Jefford, C. W., Posner, G. H., Avery, M. A. and Peter, W. (1996). Second-generation antimalarial endoperoxides. Parasitology Today 12, 79-82.
12. Mishra, S. K., Asthana, O. P., Mohanty, S., Srivastava, J. S., Satpathy, S. K., Satpathy, S., Patnaik, J. K., Rath, P. K. and Varghese, K. (1995). Effectiveness of α/β-arteether in acute falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 299-301.
13. Olliaro, P., Cattani, J. and Wirth, D. (1996). Malaria, the submerged disease. Journal of the American Medical Association 275, 230-233.
14. O'Neill, P. M. (2004). A worthy adversary for malaria. Nature, London 430, 838-839.
15. Peters, W. (1975). The chemotherapy of rodent malaria, XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity. Annals of Tropical Medicine and Parasitology 69, 155-177.
16. Peters, W. (1998) Antimalarial drugs. U.S. Patent no. 5, 834, 505.
17. Peters, W., Fleck, S. L., Robinson, B. L., Stewart, L. B. and Jefford, C. W. (2002). The chemotherapy of rodent malaria. LX. The importance of formulation in evaluating the blood schizontocidal activity of some endoperoxide antimalarials. Annals of Tropical Medicine and Parasitology 96, 559-573.
18. Peters, W., Robinson, B. L., Rossier, J. C. and Jefford, C. W. (1993a). The chemotherapy of rodent malaria XLVIII. The activities of some synthetic 1,2,4-trioxanes against chloroquine sensitive and chlorqouine resistant parasites. Part-I Studies leading to the development of novel cis-fused cyclopenteno derivatives. Annals of Tropical Medicine and Parasitology 87, 1-7.
19. Peters, W., Robinson, B. L., Rossier, J. C., Misra, D., Jefford, C. W. and Rossiter, J. C. (1993b). The chemotherapy of rodent malaria XLIX. The activities of some synthetic 1,2,4-trioxanes against chloroquine sensitive and chloroquine resistant parasites Part 2. Structure activity studies on cis-fused cyclopenteno-1,2,4-trioxanes (fenozans) against drug sensitive and drug resistant lines of Plasmodium berghei and P. yoelii spp. NS in vivo. Annals of Tropical Medicine and Parasitology 87, 9-16.
20. Peters, W., Robinson, B. L., Tovey, G., Rossier, J. C. and Jefford, C. W. (1993c). The chemotherapy of rodent malaria. The activities of some synthetic 1,2,4-trioxanes against chloroquine sensitive and chloroquine resistant parasites Part 3, Observation on 'Fenozan 50F' a difluorinated 3,3′-spirocyclopentane 1,2,4-trioxane. Annals of Tropical Medicine and Parasitology 87, 111-123.
21. Posner, G. H., Oh, C. H., Webster, H. K., Ager, Jr., A. L. and Rossan, R. N. (1994). New antimalrial, tricyclic 1,2,4-trioxanes evaluations in mice and monkey. American Journal of Tropical Medicine and Hygiene 50, 522-526.
22. Remme, J. H. F., Bias, E., Chitsulo, L., Desjeux, P. M. P., Engers, H. D., Kanyok, T. P., Kayondo, J. F. K., Kiloy, D. W., Kumaraswami, V., Lazolins, J. K., Nunn, P. P., Oduola, A., Ridley, R. G., Toure, Y. T., Zicker, F. and Marel, C. M. (2002). Strategic emphases for tropical diseases research: a TDR prospective. Trends in Parasitology 18, 421-426.
23. Tripathi, R., Dhawan, S. and Dutta, G. P. (2005). Blood schizontocidal activity of azithromycin and its combination with α/β arteether against multi-drug resistant Plasmodium yoelii nigeriensis a novel MDR parasite model for antimalarial screening. Parasitology 131, 295-301.
24. Vennerstrom, J. L., ArbeBarnes, S., Brun, R., Charman, S. A., Chiu, F. C., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., McIntosh, K., Padmanilayam, M., SantoTomas, J., Scheurer, C., Scorneaux, B., Tang, Y., Urwyler, H., Wittlin, S. and Charman, W. N. (2004). Identification of an antimalarial synthetic trioxolane drug development candidate. Nature, London 430, 900-904.
25. Wellems, T. E. (1991). Molecular genetics of drug resistance in Plasmodium falciparum malaria. Parasitology Today 7, 110-112.
26. World Health Organization (2000). Implementation of collaborative activities on 'Roll Back Malaria' in the South-East Asia Region. World Health Organization, Regional Office for South-East Asia, New Delhi, June, pp. 1-24.
27. WHO News (2003). Malaria kills 3000 children a day in Africa. Bulletin of the World Health Organization 81, 472.
28. Zaman, S. S. and Sharma, R. P. (1991). Some aspects of the chemistry and biological activity of artemisinin and related antimalarials. Heterocycles 32, 1593-1638.